Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Doc Bones who wrote (868)	3/19/2000 4:11:00 PM
From: dalroi	Read Replies (2) \| Respond to of 52153

hi doc, thanks for supporting the thesis on CLL which got clobbred on MYLOTARG simply a good buying opportunity as mylotarg is now being recommendet for use above 60 years donno how it goes in your country but here i think if the stuff proves it in that cat we would get it used in patients under 60 first in people with a bad karnovsky and then.... price target is 20œ / share on london got in again :-) BTW asm.L is ridiculous undervalued if compared with AXO.TO isnt it RWR ??